These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 7299539

  • 1. Response to long-term deferoxamine therapy in thalassemia.
    Cohen A, Martin M, Schwartz E.
    J Pediatr; 1981 Nov; 99(5):689-94. PubMed ID: 7299539
    [Abstract] [Full Text] [Related]

  • 2. Reduction in tissue iron stores with a new regimen of continuous ambulatory intravenous deferoxamine.
    Olivieri NF, Berriman AM, Tyler BJ, Davis SA, Francombe WH, Liu PP.
    Am J Hematol; 1992 Sep; 41(1):61-3. PubMed ID: 1503101
    [Abstract] [Full Text] [Related]

  • 3. Iron chelation therapy with deferoxamine in Cooley anemia.
    Cohen A, Schwartz E.
    J Pediatr; 1978 Apr; 92(4):643-7. PubMed ID: 633031
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Iron chelation in thalassemia: mechanism of desferrioxamine action.
    Hershko C, Rachmilewitz EA.
    Isr J Med Sci; 1978 Nov; 14(11):1111-5. PubMed ID: 750535
    [Abstract] [Full Text] [Related]

  • 8. Intensive iron chelation therapy in beta-thalassemia major: some effects on iron metabolism and blood transfusion dependence.
    Silvestroni E, Bianco I, Graziani B, Lerone M, Valente M, Congedo P, Ponzini D, Costantini S.
    Acta Haematol; 1982 Nov; 68(2):115-23. PubMed ID: 6812366
    [Abstract] [Full Text] [Related]

  • 9. Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia.
    Cossu P, Toccafondi C, Vardeu F, Sanna G, Frau F, Lobrano R, Cornacchia G, Nucaro A, Bertolino F, Loi A, De Virgiliis S, Cao A.
    Eur J Pediatr; 1981 Nov; 137(3):267-71. PubMed ID: 7318837
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combined therapy with desferrioxamine and deferiprone: a new protocol for iron chelation in thalassemia.
    D'Angelo E, Mirra N, Rocca A, Carnelli V.
    J Pediatr Hematol Oncol; 2004 Jul; 26(7):451-3. PubMed ID: 15218422
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Study of intermittent intravenous deferrioxamine high-dose therapy in heavily iron-loaded children with beta-thalassemia major poorly compliant to subcutaneous injections.
    Wali YA, Taqi A, Deghaidi A.
    Pediatr Hematol Oncol; 2004 Jul; 21(5):453-60. PubMed ID: 15205089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.